Clinical and Biological Characteristics Associated with In Vitro Activity of Anti-CD20 Monoclonal Antibodies, Rituximab and GA101, Against Chronic Lymphocytic Leukemia Cells - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Blood Année : 2010

Clinical and Biological Characteristics Associated with In Vitro Activity of Anti-CD20 Monoclonal Antibodies, Rituximab and GA101, Against Chronic Lymphocytic Leukemia Cells

Emilie Laprévotte
  • Fonction : Auteur
Guy Laurent
  • Fonction : Auteur
  • PersonId : 948581
Jean-Jacques Fournié

Domaines

Cancer Immunologie
Fichier non déposé

Dates et versions

hal-02348933 , version 1 (05-11-2019)

Identifiants

Citer

Loic Ysebaert, Emilie Laprévotte, Christian Klein, Guy Laurent, Jean-Jacques Fournié, et al.. Clinical and Biological Characteristics Associated with In Vitro Activity of Anti-CD20 Monoclonal Antibodies, Rituximab and GA101, Against Chronic Lymphocytic Leukemia Cells. Blood, 2010, 116 (21), pp.2459-2459. ⟨10.1182/blood.V116.21.2459.2459⟩. ⟨hal-02348933⟩
23 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More